RNAC - Cartesian Therapeutics, Inc.

QQQ $ 454.82 $ 1.24 (0.27 %)

DIA $ 398.57 $ 1.27 (0.33 %)

SPY $ 530.36 $ 0.59 (0.11 %)

TLT $ 91.26 $ 1.07 (1.17 %)

GLD $ 225.37 $ -1.95 (-0.9 %)

Previous Close

$ 35.77

Open

$ 35.70

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 34.54 - $ 37.42

52 Week Range

$ 11.67 - $ 42.60

Volume

81,506

Average Volume

Market Cap

193.66M

Beta (5Y Monthly)

$ 1.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-07-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-17-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-02-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-12-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-15-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-15-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-11-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-28-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Initiates Coverage On Cartesia...
06/04/2024 12:07:03

Oppenheimer analyst Matthew Biegler initiates coverage on Cartesian Therapeutics (NASDAQ:RNAC) with a Outperform rating and ...

Mizuho Initiates Coverage On Cartesian The...
05/24/2024 11:22:10

Mizuho analyst Uy Ear initiates coverage on Cartesian Therapeutics (NASDAQ:RNAC) with a Buy rating and announces Price Targe...

HC Wainwright & Co. Reiterates Buy on Cart...
05/23/2024 10:50:15

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Cartesian Therapeutics (NASDAQ:RNAC) with a Buy and maintains $54...

Cartesian Therapeutics Secures FDA Regener...
05/22/2024 11:01:07

HC Wainwright & Co. Reiterates Buy on Cart...
05/09/2024 19:24:06

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Cartesian Therapeutics (NASDAQ:RNAC) with a Buy and maintains $54...

Needham Reiterates Buy on Cartesian Therap...
05/08/2024 15:40:24

Needham analyst Gil Blum reiterates Cartesian Therapeutics (NASDAQ:RNAC) with a Buy and maintains $42 price target.

Cartesian Therapeutics' Approximately $104...
05/08/2024 11:22:47

Cartesian Therapeutics Q1 2024 GAAP EPS $(...
05/08/2024 11:22:08

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

HC Wainwright & Co. Maintains Buy on Carte...
04/23/2024 16:26:45

HC Wainwright & Co. analyst Mitchell Kapoor maintains Cartesian Therapeutics (NASDAQ:RNAC) with a Buy, adjusts target to...

healthstream-reports-upbeat-results-joins-spotify-ryder-system-and-other-big-stocks-moving-higher-on-tuesday

HealthStream Reports Upbeat Results, Joins...
04/23/2024 14:50:19

Leerink Partners Initiates Coverage On Car...
04/23/2024 13:44:11

Leerink Partners analyst Thomas Smith initiates coverage on Cartesian Therapeutics (NASDAQ:RNAC) with a Outperform rating an...

why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Skillsoft Shares Are Trading Lower By ...
04/16/2024 18:17:57

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/15/2024 12:07:12

cartesian-therapeutics-rare-disease-candidate-shows-long-lasting-benefit-over-argenxs-vyvgart-analyst-initiates-with-buy

Cartesian Therapeutics' Rare Disease Candi...
04/10/2024 18:34:58

Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising ant...

Needham Reiterates Buy on Cartesian Therap...
04/10/2024 11:17:47

Needham analyst Gil Blum reiterates Cartesian Therapeutics (NASDAQ:RNAC) with a Buy and maintains $42 price target.

Needham Initiates Coverage On Cartesian Th...
04/09/2024 16:17:48

Needham analyst Gil Blum initiates coverage on Cartesian Therapeutics (NASDAQ:RNAC) with a Buy rating and announces Price Ta...

Trading Halt: Halt status updated at 8:55:...
04/05/2024 12:55:04

Trading Halt: Halted at 7:50:00 p.m. ET - ...
04/04/2024 23:50:04

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
03/28/2024 20:31:16